For over a decade, Atlas Public Health has led the development and deployment of technology to address community healthcare concerns. Our solutions protect public health safety and improve patient treatment outcomes in numerous ways—from active disease and infection surveillance, outbreak management, real-time infection alerts, case management, creation of actionable data and reports, and support for state and federal reporting mandates.

ASSESS HEALTH RISKS
MONITOR INFECTION AND DISEASE DATA IN REAL TIME
Efficiently track patient data throughout a hospital stay and seamlessly merge multiple data sources without manual or duplicate effort. Visualization of increasing versus declining healthcare-acquired infections combined with a powerful, automated infection alert system lead to proactive patient care decisions and stronger risk management.

OBSERVE COMMUNITY INFECTIOUS DISEASE TRENDS
IMPLEMENT TIMELY TREATMENT AND CONTAINMENT RESPONSES
ATLAS provides solutions for communicable disease and bio-terrorism surveillance, contact tracing, outbreak investigation, case management and reporting. Our products have the power to manage a statewide response to a pandemic, while having the practical tools to manage routine communicable disease surveillance case work.

FULFILL PUBLIC HEALTH REPORTING OBLIGATIONS
EFFECTIVELY COMMUNICATE WITH AGENCIES IN APPROVED
ELECTRONIC FORMATS
As the provider of sophisticated public health surveillance systems to county and state public health departments for over ten years, ATLAS was among the first organizations to enable the automated electronic transmission of notifiable disease condition reports using CDC/PHIN compliant messaging formats opening the door to Meaningful Use fulfillment.

Learn how a partnership with Atlas Public Health will provide more effective strategies for promoting and protecting your community health concerns. Meet surveillance needs, receive timely alerts, control outbreaks proactively, generate reports and comply with public health mandates—be prepared with ATLAS.